Atlas Trials

Lung EpiCheck Biomarkers Development Study

Clinical trial NCT06245876 · UNKNOWN

Trial details

NCT number
NCT06245876
Sponsor
Nucleix Ltd.
Status
UNKNOWN
Study type
OBSERVATIONAL
Lung Cancer
Start date
2022-05-17
Primary completion
2025-12-31
Enrollment
6000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.